مكتبة

Item request has been placed!

Item request cannot be made.

Processing Request

Academic Journal

Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor Immunotherapy.

Authors : Prasse N; Research Institute Children's Cancer Center Hamburg, 20251 Hamburg, Germany.; Wessolowski C

Subjects: Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/therapy ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/immunology ; Osteosarcoma*/Osteosarcoma*/Osteosarcoma*/metabolism

Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 14; Vol. 25 (10). Date of Electronic Publication: 2024 May 14.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer.

Authors : Wu B; Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, 110136, China.; Huang X

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/immunology ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/therapy ; Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy

Source: Molecular cancer [Mol Cancer] 2024 Sep 02; Vol. 23 (1), pp. 184. Date of Electronic Publication: 2024 Sep 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the "all-around warrior" in immunotherapy.

Authors : Liu Q; Department of Urology, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, 110042, China.; Guan Y

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/Programmed Cell Death 1 Receptor*/metabolism ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods

Source: Molecular cancer [Mol Cancer] 2024 Sep 02; Vol. 23 (1), pp. 183. Date of Electronic Publication: 2024 Sep 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

NY-ESO-1 antigen: A promising frontier in cancer immunotherapy.

Authors : Alsalloum A; Laboratory of Molecular Immunology, Federal State Budgetary Scientific Institution Research Institute of Fundamental and Clinical Immunology, Novosibirsk, Russia.; Faculty of Natural Sciences, Novosibirsk State University, Novosibirsk, Russia.

Subjects: Antigens, Neoplasm*/Antigens, Neoplasm*/Antigens, Neoplasm*/immunology ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Neoplasms*/Neoplasms*/Neoplasms*/therapy

Source: Clinical and translational medicine [Clin Transl Med] 2024 Sep; Vol. 14 (9), pp. e70020.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet ISSN: 2001-1326

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Dual Adjuvant-Loaded Peptide Antigen Self-Assembly Potentiates Dendritic Cell-Mediated Tumor Immunotherapy.

Authors : Kim J; Department of Bioengineering, Institute for Bioengineering and Biopharmaceutical Research, Hanyang University, Seoul, 04763, Republic of Korea.; Kang S

Subjects: Dendritic Cells*/Dendritic Cells*/Dendritic Cells*/immunology ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Adjuvants, Immunologic*/Adjuvants, Immunologic*/Adjuvants, Immunologic*/administration & dosage

Source: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Sep; Vol. 11 (36), pp. e2403663. Date of Electronic Publication: 2024 Jul 29.Publisher: WILEY-VCH Country of Publication: Germany NLM ID: 101664569 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2198-3844

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer.

Authors : Cheng W; Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.; Kang K

Subjects: B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/antagonists & inhibitors ; CTLA-4 Antigen*/CTLA-4 Antigen*/CTLA-4 Antigen*/antagonists & inhibitors ; Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/Immune Checkpoint Inhibitors*/therapeutic use

Source: Journal of hematology & oncology [J Hematol Oncol] 2024 Jul 27; Vol. 17 (1), pp. 54. Date of Electronic Publication: 2024 Jul 27.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer.

Authors : Wang Y; Department of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200092, China.; Chen Y

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Click Chemistry* ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Aug 01; Vol. 22 (1), pp. 461. Date of Electronic Publication: 2024 Aug 01.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Histone acetylation risk model predicts prognosis and guides therapy selection in glioblastoma: implications for chemotherapy and anti-CTLA-4 immunotherapy.

Authors : Jin X; Neurosurgery Department, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.; Qin Z

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/immunology ; Glioblastoma*/Glioblastoma*/Glioblastoma*/therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/drug therapy

Source: BMC immunology [BMC Immunol] 2024 Jul 27; Vol. 25 (1), pp. 51. Date of Electronic Publication: 2024 Jul 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100966980 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2172

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

PD-L1 siRNA hitched polyethyleneimine-elastase constituting nanovesicle induces tumor immunogenicity and PD-L1 silencing for synergistic antitumor immunotherapy.

Authors : Du L; The Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.; Biobank, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

Subjects: Polyethyleneimine*/Polyethyleneimine*/Polyethyleneimine*/chemistry ; RNA, Small Interfering*/RNA, Small Interfering*/RNA, Small Interfering*/chemistry ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Jul 27; Vol. 22 (1), pp. 442. Date of Electronic Publication: 2024 Jul 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy.

Authors : Gong Y; Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, The Tianjin Key Laboratory of Biomaterials, Institute of Biomedical Engineering, Peking Union Medical College & Chinese Academy of Medical Sciences, Tianjin, 300192, China.; Gao W

Subjects: Phagocytosis* ; Immunotherapy*/Immunotherapy*/Immunotherapy*/methods ; Nanoparticles*/Nanoparticles*/Nanoparticles*/chemistry

Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 Jun 18; Vol. 22 (1), pp. 341. Date of Electronic Publication: 2024 Jun 18.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

نتائج البحث

فلترة النتائج

Glycan Structures in Osteosarcoma as Targets for Lectin-Based Chimeric Antigen Receptor Immunotherapy.

LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancer.

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the "all-around warrior" in immunotherapy.

NY-ESO-1 antigen: A promising frontier in cancer immunotherapy.

Dual Adjuvant-Loaded Peptide Antigen Self-Assembly Potentiates Dendritic Cell-Mediated Tumor Immunotherapy.

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer.

Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer.

Histone acetylation risk model predicts prognosis and guides therapy selection in glioblastoma: implications for chemotherapy and anti-CTLA-4 immunotherapy.

PD-L1 siRNA hitched polyethyleneimine-elastase constituting nanovesicle induces tumor immunogenicity and PD-L1 silencing for synergistic antitumor immunotherapy.

Engineering nanoparticles-enabled tumor-associated macrophages repolarization and phagocytosis restoration for enhanced cancer immunotherapy.

اتصل بنا

اتبع